{"lastClose": 8.710000038146973, "len": 573, "date": "2023-03-20", "alpha_1": 1.3932759674331967, "beta_1": 1.1444524420955051, "drawup_1": 2.551601332904123, "sharpe_1": 1.048233474750626, "natr_1": 5.2881916087492815, "sup_1": -0.1511672601309282, "res_1": 0.2877917808165182, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 59.09090557233602, "adx_1": 16.954041655333178, "drawdown_1": -0.5017730479964511, "stratHoldSharpe_1": 1.04322924078606, "stratHoldAlpha_1": 251.70224276714305, "stratHoldDrawdown_1": -0.4552278790763441, "alpha_3mo": -0.015281206881596954, "beta_3mo": 0.705245188228514, "drawup_3mo": 0.4236803447049582, "natr_3mo": 5.2881916087492815, "sup_3mo": -0.05721392571800496, "res_3mo": 0.024492933047063015, "bullPattern_3mo": ["3OUTSIDE"], "bearPattern_3mo": [], "rsi_3mo": 61.15107432414353, "adx_3mo": 44.12234789688914, "drawdown_3mo": -0.23947890774280378, "stratHoldSharpe_3mo": 1.4647124211612197, "stratHoldAlpha_3mo": 251.89622100461634, "stratHoldDrawdown_3mo": -0.22159261790222928, "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United Kingdom", "Market Cap": 6605902219, "Name": "Roivant Sciences Ltd.", "alpha%_1": 0.9999985969446958, "beta%_1": 0.636428298694283, "drawup%_1": 0.9999999931584669, "sharpe%_1": 0.8303071257871163, "natr%_1": 0.6587947869495971, "drawdown%_1": 0.2708559699039201, "stratHoldSharpe%_1": 0.9348067479317546, "stratHoldAlpha%_1": 0.9971800496016042, "stratHoldDrawdown%_1": 0.2733528388433943, "alpha%_3mo": 0.4075402048021114, "beta%_3mo": 0.2894456630665662, "drawup%_3mo": 0.8698981922456235, "natr%_3mo": 0.652952519747864, "drawdown%_3mo": 0.318164358463084, "stratHoldSharpe%_3mo": 0.7649309530992161, "stratHoldAlpha%_3mo": 0.9238470644904511, "stratHoldDrawdown%_3mo": 0.309794669559619}